Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth ...
Bank OZK preferred OZKAP yields over 7% after a 10% drop, backed by strong dividend coverage, and easing CRE risk metrics.
The HBO Max series has generated new interest in the "Game Changers" book series that it's based on and drawn attention to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback